Profil
Michael J.
Otto is currently the Director at Eleison Pharmaceuticals, Inc. and the President at Mjo Consulting LLC.
He previously worked as the Associate Director at Rhone-Poulenc Rorer Pharmaceuticals, Inc., Research Manager at DuPont Pharmaceuticals Co., Vice President-Research & Development at Avid Therapeutics, Inc., and Chief Scientific Officer at Pharmasset, Inc. He also served as an Independent Director at ContraFect Corp.
from 2014 to 2023.
Dr. Otto holds an undergraduate degree from Loyola University of Chicago and a doctorate from The Medical College of Wisconsin, Inc.
Aktive Positionen von Michael Otto
| Unternehmen | Position | Beginn |
|---|---|---|
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Direktor/Vorstandsmitglied | 01.01.2019 |
Mjo Consulting LLC | Präsident | 01.01.2019 |
Ehemalige bekannte Positionen von Michael Otto
| Unternehmen | Position | Ende |
|---|---|---|
| CONTRAFECT CORPORATION | Direktor/Vorstandsmitglied | 04.12.2023 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Technik-/Wissenschafts-/F&E-Leiter | 13.01.2012 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01.09.1999 |
Avid Therapeutics, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Corporate Officer/Principal | 01.01.1994 |
Ausbildung von Michael Otto
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Medical College of Wisconsin, Inc.
The Medical College of Wisconsin, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Avid Therapeutics, Inc. | |
ContraFect Corp.
ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mjo Consulting LLC |
















